跳至主要内容
临床试验/JPRN-UMIN000008768
JPRN-UMIN000008768已完成未知

An randomized comparative study of efficacy and safety between mirtazapine and duloxetine hydrochloride in patients with cancer - An randomized comparative study of efficacy and safety between mirtazapine and duloxetine hydrochloride in patients

Fukuoka University Faculty of Medicine Department of Psychiarty0 个研究点目标入组 20 人开始时间: 2012年8月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Brain metastasis confirmed 2)Congnitive impairment 3)Under interferon therapy 4)Bipolar disorder 5)Convulsive disorder or history of convulsive disorder 6)Prior electroconvulsive therapy 7)Dysuria, glaucoma or treatment for elevated intraocular pressure 8)Administration of the monoamine oxidase (MAO) inhibitor within observation period(2 weeks) 9)Hypersensitivity to mirtazapine or duloxetine hydrochloride 10)Pregnancy or lactating woman, woman planning pregnancy 11)Substance or alcohol abuse 180 days prior to administration of investigational drug. 12)Patient ineligible to the study based on investigator's decision.

研究者

发起方
Fukuoka University Faculty of Medicine Department of Psychiarty

相似试验